Literature DB >> 17682063

MafA stability in pancreatic beta cells is regulated by glucose and is dependent on its constitutive phosphorylation at multiple sites by glycogen synthase kinase 3.

Song-Iee Han1, Shinsaku Aramata, Kunio Yasuda, Kohsuke Kataoka.   

Abstract

Regulation of insulin gene expression by glucose in pancreatic beta cells is largely dependent on a cis-regulatory element, termed RIPE3b/C1, in the insulin gene promoter. MafA, a member of the Maf family of basic leucine zipper (bZip) proteins, is a beta-cell-specific transcriptional activator that binds to the C1 element. Based on increased C1-binding activity, MafA protein levels appear to be up-regulated in response to glucose, but the underlying molecular mechanism for this is not well understood. In this study, we show evidence supporting that the amino-terminal region of MafA is phosphorylated at multiple sites by glycogen synthase kinase 3 (GSK3) in beta cells. Mutational analysis of MafA and pharmacological inhibition of GSK3 in MIN6 beta cells strongly suggest that the rate of MafA protein degradation is regulated by glucose, that MafA is constitutively phosphorylated by GSK3, and that phosphorylation is a prerequisite for rapid degradation of MafA under low-glucose conditions. Our data suggest a new glucose-sensing signaling pathway in islet beta cells that regulates insulin gene expression through the regulation of MafA protein stability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17682063      PMCID: PMC2099218          DOI: 10.1128/MCB.01573-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  Maf and Jun nuclear oncoproteins share downstream target genes for inducing cell transformation.

Authors:  K Kataoka; S Shioda; K Yoshitomo-Nakagawa; H Handa; M Nishizawa
Journal:  J Biol Chem       Date:  2001-07-18       Impact factor: 5.157

2.  Phosphorylation of MafA is essential for its transcriptional and biological properties.

Authors:  S Benkhelifa; S Provot; E Nabais; A Eychène; G Calothy; M P Felder-Schmittbuhl
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

3.  Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.

Authors:  E H Hani; D A Stoffers; J C Chèvre; E Durand; V Stanojevic; C Dina; J F Habener; P Froguel
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

4.  Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus.

Authors:  M T Malecki; U S Jhala; A Antonellis; L Fields; A Doria; T Orban; M Saad; J H Warram; M Montminy; A S Krolewski
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

5.  A crucial role of MafA as a novel therapeutic target for diabetes.

Authors:  Hideaki Kaneto; Taka-aki Matsuoka; Yoshihisa Nakatani; Takeshi Miyatsuka; Munehide Matsuhisa; Masatsugu Hori; Yoshimitsu Yamasaki
Journal:  J Biol Chem       Date:  2005-01-20       Impact factor: 5.157

6.  Phosphorylation-dependent nucleocytoplasmic shuttling of pancreatic duodenal homeobox-1.

Authors:  L J Elrick; K Docherty
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

7.  Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.

Authors:  Chunming Liu; Yiming Li; Mikhail Semenov; Chun Han; Gyeong Hun Baeg; Yi Tan; Zhuohua Zhang; Xinhua Lin; Xi He
Journal:  Cell       Date:  2002-03-22       Impact factor: 41.582

8.  Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA.

Authors:  Martin Olbrot; Jonathan Rud; Larry G Moss; Arun Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

9.  A set of Hox proteins interact with the Maf oncoprotein to inhibit its DNA binding, transactivation, and transforming activities.

Authors:  K Kataoka; K Yoshitomo-Nakagawa; S Shioda; M Nishizawa
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

10.  Glucose-stimulated preproinsulin gene expression and nuclear trans-location of pancreatic duodenum homeobox-1 require activation of phosphatidylinositol 3-kinase but not p38 MAPK/SAPK2.

Authors:  I Rafiq; G da Silva Xavier; S Hooper; G A Rutter
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

View more
  41 in total

1.  A small molecule differentiation inducer increases insulin production by pancreatic β cells.

Authors:  Elhadji M Dioum; Jihan K Osborne; Sean Goetsch; Jamie Russell; Jay W Schneider; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 2.  Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

Authors:  Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

3.  ATF2 interacts with beta-cell-enriched transcription factors, MafA, Pdx1, and beta2, and activates insulin gene transcription.

Authors:  Song-iee Han; Kunio Yasuda; Kohsuke Kataoka
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

4.  Sumoylation regulates the transcriptional activity of MafA in pancreatic beta cells.

Authors:  Chunli Shao; Melanie H Cobb
Journal:  J Biol Chem       Date:  2008-11-22       Impact factor: 5.157

5.  Phosphorylation within the MafA N terminus regulates C-terminal dimerization and DNA binding.

Authors:  Shuangli Guo; Nathan L Vanderford; Roland Stein
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

6.  Notch signaling dynamically regulates adult β cell proliferation and maturity.

Authors:  Alberto Bartolome; Changyu Zhu; Lori Sussel; Utpal B Pajvani
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

7.  MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma.

Authors:  Ya-Wei Qiang; Shiqiao Ye; Yu Chen; Amy F Buros; Ricky Edmonson; Frits van Rhee; Bart Barlogie; Joshua Epstein; Gareth J Morgan; Faith E Davies
Journal:  Blood       Date:  2016-10-28       Impact factor: 22.113

8.  Glucose regulates steady-state levels of PDX1 via the reciprocal actions of GSK3 and AKT kinases.

Authors:  Rohan K Humphrey; Shu-Mei Yu; Luis E Flores; Ulupi S Jhala
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

9.  Regulation of protein stability by GSK3 mediated phosphorylation.

Authors:  Chong Xu; Nam-Gyun Kim; Barry M Gumbiner
Journal:  Cell Cycle       Date:  2009-12-17       Impact factor: 4.534

10.  p38 MAPK is a major regulator of MafA protein stability under oxidative stress.

Authors:  Takuma Kondo; Ilham El Khattabi; Wataru Nishimura; D Ross Laybutt; Pedro Geraldes; Samit Shah; George King; Susan Bonner-Weir; Gordon Weir; Arun Sharma
Journal:  Mol Endocrinol       Date:  2009-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.